Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by ImmunoPrecise Antibodies Ltd. < Previous 1 2 Next > ImmunoPrecise to Host TECHDAY: Cutting-Edge AI and Biologics Innovation Today 8:01 EST From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA ImmunoPrecise Advances Anti-Aging Research with Mayo Clinic Study, Poised to Tap into $81 Billion Market with AI Technology October 28, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA ImmunoPrecise Antibodies to Participate at the AI Driven Drug Discovery Summit USA 2024 October 21, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA ImmunoPrecise Antibodies Celebrates Nobel Prize in Chemistry, Advances in AI-Powered Protein Design October 10, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA ImmunoPrecise Subsidiary Signs Material Transfer Agreement with Biotheus October 02, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA ImmunoPrecise Antibodies Advances Therapeutic Innovation with Groundbreaking Rabbit Antibody Developments September 26, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2025 September 16, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA IPA to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2025 on September 16, 2024 September 09, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA ImmunoPrecise Antibodies to Participate at H.C. Wainwright's 26th Annual Global Investment Conference in New York August 26, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA ImmunoPrecise Antibodies Receives Nasdaq Notification Regarding Minimum Bid Requirements August 23, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA ImmunoPrecise Antibodies (IPA) Reports Financial Results and Business Updates for Fourth Quarter and Full Fiscal Year 2024 July 29, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA ImmunoPrecise Antibodies to Reschedule Financial Results and Recent Business Highlights Report for Fourth Quarter and Fiscal Year-End 2024 July 23, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA ImmunoPrecise Announces Financing Agreement with Yorkville Advisors Global, LP of up to $3.0 Million Aggregate Principal Amount of Convertible Debentures July 16, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA IPA to Report Financial Results and Recent Business Highlights for Fourth Quarter and Fiscal Year End 2024 on July 25th, 2024 July 15, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA ImmunoPrecise Appoints Kristin Taylor as Chief Financial Officer June 27, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA IPA’s Subsidiary BioStrand and PGxAI Announce Strategic Collaboration to Develop First-In-Class AI Model for Pharmacogenomics Recommendations Using LENSai™ June 25, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA ImmunoPrecise Antibodies Ltd. Subsidiary BioStrand Receives Prestigious 2024 Impact Award for Groundbreaking LENSai™ Technology June 12, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA BioStrand, ImmunoPrecise Antibodies’ Subsidiary, Announces Immediate Commercial Offering of Groundbreaking Software with Customizable Interface for AI-Driven Drug Discovery June 10, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA IPA’s Subsidiary, BioStrand, Announces Advanced Large Language Model (LLM) for Electronic Health Records (EHR) June 04, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA InterSystems and IPA’s Subsidiary BioStrand Collaborate to Unveil the Innovative Integration of Vector Search with LENSai for AI-Driven Healthcare Applications March 28, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA IPA Acquires the Carterra LSA® Instrument to Enhance Antibody Discovery and Bolster Its AI Developments March 20, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA IPA Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2024* March 14, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA IPA’s subsidiary BioStrand Unveils Major Breakthrough in Life Sciences with Advanced Foundation AI Model Utilizing LLM Stacking and HYFT Technology March 07, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA IPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2024 on March 14, 2024 March 04, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA IPA Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2024* December 14, 2023 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA IPA Announces Closing of $1.265 Million Public Offering of Common Shares December 08, 2023 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA IPA Announces Pricing of $1.1 Million Public Offering of Common Shares December 06, 2023 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA IPA Announces Proposed Public Offering of Common Shares December 05, 2023 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA ImmunoPrecise Antibodies Ltd. Announces Key Board and Board Committee Chair Appointments and Second Quarter 2024 Earnings Release Call November 27, 2023 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA BioStrand® Unveils a Revolutionary Approach to Biological Sequence Retrieval: A Fusion of Natural Language Processing and Database Research November 13, 2023 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
